Torento 90

Etoricoxib
90mg
SinoHealth Pharmaceuticals LTD

Description

💊 Terento 90 – Etoricoxib 90 mg Tablet

Manufacturer: SinoHealth Pharmaceuticals LTD


1. Indications:

Torento 90 is indicated for the symptomatic relief of:

  • Osteoarthritis (OA)

  • Rheumatoid Arthritis (RA)

  • Ankylosing Spondylitis

  • Pain and inflammation associated with acute gouty arthritis

  • Short-term treatment of moderate pain after dental surgery

āϰ⧇āϜāĻŋāĻ¸ā§āϟāĻžāĻ°ā§āĻĄ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻŽā§‹āϤāĻžāĻŦ⧇āĻ• āĻ”āώāϧ āϏ⧇āĻŦāύ āĻ•āϰ⧁āύāĨ¤


2. Pharmacology:

Etoricoxib is a potent, orally active, COX-2 selective inhibitor.

There are two forms of cyclooxygenase:

  • COX-1: Responsible for normal physiological functions such as gastric protection and platelet aggregation.

  • COX-2: Mainly responsible for the synthesis of prostaglandins that cause pain, inflammation, and fever.

By selectively inhibiting COX-2, Etoricoxib relieves pain and inflammation without affecting COX-1, reducing the risk of gastric damage and bleeding.
At doses up to 90 mg daily, Etoricoxib inhibits COX-2 without inhibiting gastric prostaglandin synthesis.


3. Dosage & Administration:

Adults and adolescents (16 years and older):

  • Osteoarthritis: 30 mg once daily (may increase to 60 mg if needed).

  • Rheumatoid Arthritis: 90 mg once daily.

  • Ankylosing Spondylitis: 90 mg once daily.

  • Acute Gouty Arthritis: 90 mg once daily (short-term as per physician).

  • Postoperative Dental Pain: 90 mg once daily (up to 3 days).

âš ī¸ Use the lowest effective dose for the shortest possible duration.
Reassess the patient’s need for continued therapy periodically.

āϰ⧇āϜāĻŋāĻ¸ā§āϟāĻžāĻ°ā§āĻĄ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻŽā§‹āϤāĻžāĻŦ⧇āĻ• āĻ”āώāϧ āϏ⧇āĻŦāύ āĻ•āϰ⧁āύāĨ¤


4. Drug Interactions:

With Medicines:

  • Warfarin: May increase prothrombin time.

  • Diuretics, ACE inhibitors, Angiotensin II antagonists: May reduce antihypertensive effects.

  • Low-dose Aspirin: Can be used together for cardiovascular prophylaxis.

  • Ciclosporin or Tacrolimus: May increase nephrotoxicity risk.

  • Lithium: May increase lithium levels by reducing renal excretion.

With Food:

  • Can be taken with or without food.


5. Contraindications:

  • Hypersensitivity to Etoricoxib or any excipients

  • Active peptic ulcer or gastrointestinal bleeding

  • History of asthma, urticaria, or allergic reactions to NSAIDs or aspirin

  • Pregnancy and lactation

  • Severe hepatic impairment (Child-Pugh â‰Ĩ10 or serum albumin <25 g/L)

  • Renal impairment (CrCl <30 mL/min)

  • Children under 16 years

  • Inflammatory bowel disease

  • Congestive heart failure (NYHA II–IV)

  • Uncontrolled hypertension (â‰Ĩ140/90 mmHg)

  • Established ischemic heart disease, peripheral arterial disease, or cerebrovascular disease


6. Side Effects:

  • Common: Palpitation, fatigue, influenza-like symptoms, dizziness

  • Less common: Dry mouth, taste disturbance, appetite change, atrial fibrillation, cough, dyspnoea, anxiety

  • Rare: Confusion, hallucinations, weight change, mouth ulcer, paraesthesia, muscle/joint pain


7. Pregnancy & Lactation:

  • Not recommended for women attempting to conceive.

  • Contraindicated during pregnancy and lactation.

  • Excreted in rat milk; human excretion unknown.


8. Precautions & Warnings:

  • Use cautiously in elderly patients and those with a history of ulcers or GI bleeding.

  • Monitor patients with cardiovascular risk factors (hypertension, diabetes, smoking).

  • Monitor renal function in patients with dehydration, renal impairment, or heart failure.

  • Discontinue if liver dysfunction or abnormal LFTs occur.

  • Stop treatment if skin rash or hypersensitivity appears.

  • May mask fever or signs of infection.

  • Caution when co-administered with warfarin or anticoagulants.


9. Overdose Effects:

  • Single doses up to 500 mg or multiple doses up to 150 mg/day show no major toxicity.

  • In overdose: apply supportive measures — gastric lavage, monitoring, and symptomatic care.


10. Therapeutic Class:

Non-Steroidal Anti-Inflammatory Drug (NSAID) – COX-2 Selective Inhibitor


11. Storage Conditions:

  • Store below 30°C, protected from light and moisture.

  • Keep all medicines out of the reach of children.